CONSEQUENCES OF HYPOPITUITARISM FOLLOWING TRAUMATIC BRAIN INJURY (TBI)

创伤性脑损伤 (TBI) 后垂体机能减退的后果

基本信息

  • 批准号:
    7605239
  • 负责人:
  • 金额:
    $ 1.17万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-02-15 至 2007-11-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Hypotheses: This protocol will investigate the effect of traumatic brain injury (TBI)-associated hypopituitarism on body composition, quality of life (QOL), and activities of daily living (ADL). We hypothesize that: 1. TBI is associated with a high degree of hypopituitarism, including growth hormone deficiency. 2. Hypopituitarism in patients with TBI is associated with diminished skeletal muscle mass and increased body fat, decreased QOL, and decreased ability to perform ADL compared to patients with normal pituitary function. 3. In patients with history of TBI, the degree of hypopituitarism correlates with the degree of deterioration in skeletal muscle mass, body fat, QOL, and ADL. Goals: TBI has profound clinical and economic consequences. Common sequelae of injury include neurologic or neuromuscular damage, cognitive dysfunction, physical deconditioning, weight gain, or fat redistribution, as well as diminished quality of life and overall performance. These sequelae have been identified as major obstacles to successful rehabilitation. Many TBI patients fall short of complete recovery altogether and enter into a phase of chronic disability and unemployment. The syndrome of hypopituitarism is widely recognized, and the importance of replacement therapy well understood. Dysfunction of the anterior pituitary gland may lead to a compromise in growth hormone (GH), thyroid, glucocorticoid, sex hormone (testosterone in men/estrogen in women), and prolactin production. In general, patients with hypopituitarism present with fatigue and either weight gain or loss, and may have one or more hormone axes compromised. Central hypothyroidism widely impacts the respiratory, cardiovascular, neurologic, and musculoskeletal systems and therefore is associated with fatigue, poor exercise tolerance, impaired memory, and cause weakness and myopathy. Hypogonadism (testosterone deficiency) in men can lead to adverse affects on body composition, bone density, and neuropsychosocial function. Testosterone deficiency in men can have behavioral and cognitive consequences including mood disturbances, decreased verbal fluency, impaired memory, and poor QOL. There is a growing literature on the relative androgen deficiency in female patients with central hypogonadism, which may have adverse consequences on lean mass and function. Signs and symptoms of chronic adrenal insufficiency include malaise, lassitude, weakness, anorexia, and weight loss. In severe and chronic cases, patients may have neuropsychiatric manifestations such as memory loss, organic brain syndrome, depression, and overt psychosis. This pilot study will consist of a cross-sectional design with men and women between 18-55 years old 6 months following TBI. Control subjects will be identified posthoc by normal pituitary function. We will test body composition, QOL, and ADL in each subject to compare differences in hypopituitary vs. normal subjects and also correlate degree of hypopituitarism to degree of differences in outcomes.
这个子项目是众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LAURENCE KATZNELSON其他文献

LAURENCE KATZNELSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LAURENCE KATZNELSON', 18)}}的其他基金

CONSEQUENCES OF HYPOPITUITARISM FOLLOWING TRAUMATIC BRAIN INJURY (TBI)
创伤性脑损伤 (TBI) 后垂体机能减退的后果
  • 批准号:
    7717891
  • 财政年份:
    2007
  • 资助金额:
    $ 1.17万
  • 项目类别:
CLINICAL TRIAL: PASIREOTIDE IN PATIENTS WITH PERSISTENT OR RECURRENT CUSHING'S D
临床试验:帕西肽治疗持续性或复发性库欣氏病患者
  • 批准号:
    7717932
  • 财政年份:
    2007
  • 资助金额:
    $ 1.17万
  • 项目类别:
CLINICAL TRIAL: SOM230 IM LAR INJECTION IN PATIENTS WITH ACROMEGALY AND CARCIN
临床试验:SOM230 IM LAR 注射液治疗肢端肥大症和癌患者
  • 批准号:
    7717909
  • 财政年份:
    2007
  • 资助金额:
    $ 1.17万
  • 项目类别:
CONSEQUENCES OF HYPOPITUITARISM FOLLOWING TRAUMATIC BRAIN INJURY (TBI)
创伤性脑损伤 (TBI) 后垂体机能减退的后果
  • 批准号:
    7375316
  • 财政年份:
    2005
  • 资助金额:
    $ 1.17万
  • 项目类别:
Benefits of Testosterone on Strength in Elderly Men
睾酮对老年男性力量的好处
  • 批准号:
    6586430
  • 财政年份:
    2002
  • 资助金额:
    $ 1.17万
  • 项目类别:
SOMATOSTATIN ANALOGUE LANREOTIDE TREATMENT OF NEW PTS W/ ACROMEGALY
生长抑素类似物兰瑞肽治疗新发肢端肥大症
  • 批准号:
    6586371
  • 财政年份:
    2002
  • 资助金额:
    $ 1.17万
  • 项目类别:
RALOXIFENE HYDROCHLORIDE & BONE TURNOVER HORMONE LEVEL IN PROSTATE SIZE
盐酸雷洛昔芬
  • 批准号:
    6586373
  • 财政年份:
    2002
  • 资助金额:
    $ 1.17万
  • 项目类别:
SOMATOSTATIN ANALOGUE LANREOTIDE IPSTYL IN PTS W/ ACROMEGALY
生长抑素类似物兰瑞肽 IPSTYL 在PTS中伴肢端肥大症
  • 批准号:
    6586376
  • 财政年份:
    2002
  • 资助金额:
    $ 1.17万
  • 项目类别:
Benefits of Testosterone on Strength in Elderly Men
睾酮对老年男性力量的好处
  • 批准号:
    6574397
  • 财政年份:
    2001
  • 资助金额:
    $ 1.17万
  • 项目类别:
RALOXIFENE HYDROCHLORIDE & BONE TURNOVER HORMONE LEVEL IN PROSTATE SIZE
盐酸雷洛昔芬
  • 批准号:
    6574340
  • 财政年份:
    2001
  • 资助金额:
    $ 1.17万
  • 项目类别:

相似海外基金

Determining 4-Dimensional Foot Loading Profiles of Healthy Adults across Activities of Daily Living
确定健康成年人日常生活活动的 4 维足部负荷曲线
  • 批准号:
    2473795
  • 财政年份:
    2024
  • 资助金额:
    $ 1.17万
  • 项目类别:
    Studentship
Developing a trunk function assessment for hemiplegics. -For improving activities of daily living-
开发偏瘫患者的躯干功能评估。
  • 批准号:
    23K10540
  • 财政年份:
    2023
  • 资助金额:
    $ 1.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Relation with the activities of daily living and the subjective values among people with social withdrawal
社交退缩者日常生活活动与主观价值观的关系
  • 批准号:
    23K16596
  • 财政年份:
    2023
  • 资助金额:
    $ 1.17万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
CRII: RI: Understanding Activities of Daily Living in Indoor Scenarios
CRII:RI:了解室内场景中的日常生活活动
  • 批准号:
    2245652
  • 财政年份:
    2023
  • 资助金额:
    $ 1.17万
  • 项目类别:
    Standard Grant
Association between Nursing Care and Prognosis and Activities of Daily Living in Acute Stroke patients by using Big Data.
利用大数据研究急性脑卒中患者的护理与预后和日常生活活动的关系。
  • 批准号:
    23K16412
  • 财政年份:
    2023
  • 资助金额:
    $ 1.17万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Sources of vulnerability among those using homecare despite having no limitations in Activities of Daily Living. An intersectionality analysis
尽管日常生活活动没有限制,但使用家庭护理的人的脆弱性来源。
  • 批准号:
    499112
  • 财政年份:
    2023
  • 资助金额:
    $ 1.17万
  • 项目类别:
    Operating Grants
Synergizing home health rehabilitation therapy to optimize patients’ activities of daily living
协同家庭健康康复治疗,优化患者的日常生活活动
  • 批准号:
    10429480
  • 财政年份:
    2022
  • 资助金额:
    $ 1.17万
  • 项目类别:
Effects of a model of nurses-occupational therapists collaborative practice on activities of daily living in elderly patients
护士-职业治疗师合作实践模式对老年患者日常生活活动的影响
  • 批准号:
    22K17540
  • 财政年份:
    2022
  • 资助金额:
    $ 1.17万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Assessing a Novel Virtual Environment that Primes Individuals Living with AD/ADRD to Accomplish Activities of Daily Living.
评估一种新颖的虚拟环境,该环境可以帮助 AD/ADRD 患者完成日常生活活动。
  • 批准号:
    10668160
  • 财政年份:
    2022
  • 资助金额:
    $ 1.17万
  • 项目类别:
Synergizing home health rehabilitation therapy to optimize patients’ activities of daily living
协同家庭健康康复治疗,优化患者的日常生活活动
  • 批准号:
    10621820
  • 财政年份:
    2022
  • 资助金额:
    $ 1.17万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了